Development of a Computer-Aided Diagnosis System for Hepatocellular Carcinoma Microvascular Invasion Based on Preoperative Image Analysis

Status: Recruiting
Location: See all (19) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Hepatocellular carcinoma (HCC) is a common malignancy in China with a high mortality rate. Its early recurrence and long-term prognosis are closely associated with tumor aggressiveness. Microvascular invasion (MVI), defined as the presence of tumor cells within small branches of the portal or hepatic veins, is a key indicator of malignant biological behavior in HCC. Clinically, MVI is strongly correlated with postoperative early recurrence and serves as an important factor in determining surgical margin extension, adjuvant therapy, and postoperative management strategies. At present, definitive diagnosis of MVI still relies on postoperative pathological examination, and stable, effective preoperative assessment methods are lacking. Although some studies have attempted to predict MVI using preoperative imaging features, their clinical translation remains limited by poor generalizability, weak interpretability, and insufficient cross-center adaptability. This study aims to leverage multiphase preoperative CT imaging, artificial intelligence techniques, and clinical prior knowledge to develop a high-performance, generalizable, and interpretable computer-aided diagnostic system for preoperative prediction of HCC-MVI. An observational, prospective evaluation will be conducted to assess system performance and to facilitate the clinical translation of intelligent diagnostic technologies in real-world practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years.

• Confirmed diagnosis of hepatocellular carcinoma (HCC) according to the Chinese Clinical Practice Guidelines for Primary Liver Cancer.

• Eligible for surgical intervention (hepatic resection or liver transplantation) according to the Chinese Clinical Practice Guidelines for Cancer, including stages Ia, Ib, and IIa.

• Preoperative imaging examination performed within 1 month before surgery.

• Availability of histopathological evaluation with documented microvascular invasion (MVI) status.

Locations
Other Locations
China
Beijing Tsinghua Changgeng Hospital
RECRUITING
Beijing
Beijing YouAn Hospital
RECRUITING
Beijing
Peking Union Medical College Hospital
RECRUITING
Beijing
West China Hospital
RECRUITING
Chengdu
Dazhou Central Hospital
RECRUITING
Dazhou
Meng Chao Hepatobiliary Hospital of Fujian Medical University
RECRUITING
Fuzhou
Guangdong Provincial Hospital of Traditional Chinese Medicine
RECRUITING
Guangzhou
Zhujiang Hospital
RECRUITING
Guangzhou
Guizhou Provincial People's Hospital
RECRUITING
Guiyang
First Affiliated Hospital of Kunming Medical University
RECRUITING
Kunming
The First People's Hospital of Yunnan Province
RECRUITING
Kunming
Yunnan Cancer Hospital
RECRUITING
Kunming
First Affiliated Hospital of Guangxi Medical University
RECRUITING
Nanning
Eastern Hepatobiliary Surgery Hospital
RECRUITING
Shanghai
Shengjing Hospital
RECRUITING
Shenyang
First Affiliated Hospital of Wenzhou Medical University
RECRUITING
Wenzhou
Henan Provincial People's Hospital
RECRUITING
Zhengzhou
Fifth Affiliated Hospital, Sun Yat-Sen University
RECRUITING
Zhuhai
Zhuhai People's Hospital
RECRUITING
Zhuhai
Contact Information
Primary
Di Dong, Ph.D.
di.dong@ia.ac.cn
+86 13811833760
Backup
Mengjie Fang, Ph.D.
fangmengjie2015@ia.ac.cn
+86 18500909634
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 400
Treatments
Peking Union Medical College Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
First Affiliated Hospital of Kunming Medical University
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Beijing YouAn Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Zhujiang Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Meng Chao Hepatobiliary Hospital of Fujian Medical University
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
First Affiliated Hospital of Wenzhou Medical University
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Fifth Affiliated Hospital, Sun Yat-Sen University
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Henan Provincial People's Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Guangdong Provincial Hospital of Traditional Chinese Medicine
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Shengjing Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Beijing Tsinghua Changgeng Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Yunnan Cancer Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
The First People's Hospital of Yunnan Province
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Guizhou Provincial People's Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
First Affiliated Hospital of Guangxi Medical University
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
West China Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Zhuhai People's Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Dazhou Central Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Eastern Hepatobiliary Surgery Hospital
patients aged 18 years and older who undergo surgical resection for hepatocellular carcinoma with available pathological evaluation of microvascular invasion. We will collect preoperative multiphase CT images, clinical characteristics, and pathological outcomes.
Related Therapeutic Areas
Sponsors
Collaborators: Peking Union Medical College Hospital, First Affiliated Hospital of Wenzhou Medical University, Beijing Tsinghua Changgeng Hospital, West China Hospital, Yunnan Cancer Hospital, Fifth Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Kunming Medical University, Zhujiang Hospital, Eastern Hepatobiliary Surgery Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Beijing YouAn Hospital, Dazhou Central Hospital, ZhuHai Hospital, Shengjing Hospital, Henan Provincial People's Hospital, Guizhou Provincial People's Hospital, The First People's Hospital of Yunnan, First Affiliated Hospital of Guangxi Medical University, Meng Chao Hepatobiliary Hospital of Fujian Medical University
Leads: Chinese Academy of Sciences

This content was sourced from clinicaltrials.gov